'Game Changing' Apitope Plans IPO To Progress First-In-Class MS Drug

 
• By Sten Stovall
  
IPO
Apitope To IPO On EuroNext Brussels For Progressing Autoimmune Therapies • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business